The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry.

Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more.

At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution.

Links:

The chronic condition we should be talking about: Challenges and opportunities in migraine care

Learn about Advisory Board Fellowship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like everyone else, we’ve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers.

What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Board’s Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them.

Links:

3 takeaways on why primary care is key to migraine management

Register for the Revolutions in Specialty Care Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations aren’t baking health equity into their business models.

Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Board’s prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.

Links:

Register for the Clinical Innovation Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care.

That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030.

Links:

Register for the Clinical Innovation Summit

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time.

In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge – including incentives, prevailing professional and social norms, and competition – that the industry must confront to deliver better and cheaper healthcare.

Links:

Learn about Advisory Board On-Demand Courses

Learn about Advisory Board Fellowship

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution.

Links:

6 advantages to matching patients with compatible clinicians (sponsored by Optum Match)

Learn about Advisory Board Fellowship

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all.

In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss what "transformation" actually means, what conditions need to be in place to mitigate financial loss, and what leaders can do to advance towards industry-wide transformation.

Links:

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the mental wellbeing of their staff. But will the promise of a tech-enabled clinical workforce live up to the hype?

In this special episode, recorded live from ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the state of the workforce crisis, how new technologies are redefining work, and why emerging technologies like AI might not be a silver bullet.

Links:

Truly personalized care is possible. Here's how to make it a reality.

[Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward.

This week, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to talk about a new era of innovation, where progress in diagnostics, treatments, data analysis, and ongoing management have the potential to revolutionize patient care through unprecedented customization. They define what "bespoke care" is, explain how it differs from other delivery models, and highlight the opportunities (and challenges) it presents.

Want to learn more about bespoke care and what it means for the industry? Register for our upcoming webinar series in May.

Links:

New advances in treatment and diagnostics have the potential to deliver on one of healthcare's greatest unrealized promises: truly personalized, patient-focused care. But how can a system designed to deliver fast, standardized treatment realign itself to offer "bespoke care" to patients at scale? Visit advisory.com/bespoke to learn 4 key challenges standing in the way – and how to overcome them.

Radio Advisory is celebrating its four-year anniversary this month! Tell us about your favorite episode, what you like about the podcast, and how we can continue to do better by emailing [email protected] or leave us a voicemail through radioadvisory.advisory.com. Thanks for listening!

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future.

In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care.

Links:

Use the Market Scenario Planner

Learn about Advisory Board On-Demand Courses

Register for the Raising the Value Bar Summit

3 strategies for facing the 'tripledemic' of respiratory viruses

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.